Information on Lymphogranuloma Venereum (LGV) (caused by Chlamydia trachomatis)

Lymphogranuloma venereum (LGV) is a sexually transmitted illness that primarily infects the lymphatics. Lymphogranuloma venereum is reason by serovars of Chlamydia trachomatis. The bacterium is spread through sexual contact. It is rare in industrialised countries, but is endemic in parts of Africa, Asia, South America, and the Caribbean. It gains entrance through breaks in the skin, or it can cross the epithelial cell layer of mucous membranes. The organism travels from the site of inoculation down the lymphatic channels to multiply within mononuclear phagocytes of the lymph nodes it passes. The primary symptom may be a small, painless pimple or lesion occurring on the penis or vagina. It is frequently unnoticed. The infection then spreads to the lymph nodes in the groin area and from there to the surrounding tissue. Complications may comprise inflamed and swollen lymph glands which may drain and bleed. The incubation period ranges from 3 to 12 days. The primary lesion is a 5- to 8-mm, soft, red, painless erosion or ulcer. The ulcer heals spontaneously in a few days. The secondary stage begins 2 to 6 weeks later and is characterized by the appearance of tender, inguinal adenopathy, which develops with over-riding erythema and edema. The lymph nodes coalesce, may fluctuate, and drain spontaneously. Associated fever, chills, and malaise can be severe. Lymphogranuloma venereum is significantly more common in men than in women. Men are more probably to present with inguinal lymphadenopathy in the second stage of the illness. Lymphogranuloma venereum can be cured by proper antibiotic therapy. Common antibiotic treatments include: tetracycline, doxycycline (all tetracyclines, including doxycycline, are contraindicated during pregnancy and in children due to effects on bone development and tooth discoloration), and erythromycin.Aspiration of fluctuant buboes may prevent spontaneous rupture and reduce morbidity. Symptomatic treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) may be beneficial. Lymphedema in later stages may not resolve despite elimination of the organism. Fluctuant buboes may be aspirated or incised if necessary for symptomatic relief, but most patients respond quickly to antibiotics. Buboes and fistulas may require surgery, but rectal strictures can usually be dilated. Prevention is better than cure. The accurate use of condoms, either the men or women type, greatly decreases the risk of getting a sexually-transmitted disease.

Corneal Collagen Crosslinking with Riboflavin or (C3-R) is a relatively new treatment. In past decades surgeons would have to perform a corneal transplant to improve the vision of keratoconus patients. Now they have developed a new treatment that helps strengthen the cornea and stop the damage that keratoconus patients could suffer from this progressive disease.

Corneal Collagen Crosslinking with Riboflavin or (C3-R) is a relatively new treatment. In past decades surgeons would have to perform a corneal transplant to improve the vision of keratoconus patients. Now they have developed a new treatment that helps strengthen the cornea and stop the damage that keratoconus patients could suffer from this progressive disease. The Treatment Application- C3-R is directed under the epithelial cell layer. Located on the surface of the cornea. The surgeon will apply anesthesia drops on the surface of the eye. Then disrupt the epithelial cell layer. So the Riboflavin eye drops will penetrate the stromal portion of the cornea, which is the layer under the epithelium. The Riboflavin drops are then placed on the surface of the cornea. A small UVA light is shone over the eye for about 30 minutes to activate the solution. The procedure is relatively comfortable if the epithelium layer is only disrupted rather than removed. Some surgeons removed the layer, which makes the first week of the procedure uncomfortable. Be sure to check with your doctor to see if they perform the epi-on or epi-off technique. There are several benefits of Corneal Collagen Crosslinking below are a few:

Strengthens the cornea with less evasive procedures- The solution will improve the strength of the cornea over 3-6 months after treatment. It only requires a one time application. And there are less risks associated with C3-R as appose to corneal transplant. Can be combined with INTACS to reverse damage to the cornea- C3-R treatment can be mixed with INTACS reduce the cone shape of the cornea. After the 3 year follow up doctors found that it stopped the increase of cornea curvature values and flattened the mean cone. C3-R Stabilizes Progressive Ectasia- C3-R can give some relief from Progressive Ectasia. It has been proven to stabilize progressive Ectasia. While it is not a complete cure there are high hopes for further treatments of Ectasia. The benefits of C3-R many. Surgeons are further studying and researching C3-R and INTACS. Without question medical sciences are growing rapidly. And each day we are improving the treatments for Keratoconus and other troubling diseases. There is no need to suffer with Keratoconus. Patients now have a wide array of treatments to help them with the progression of this condition.

Article Source: http://www.BestToRead.com/

Corneal Collagen Crosslinking with Riboflavin or (C3-R) is a relatively new treatment. In past decades surgeons would have to perform a corneal transplant to improve the vision of keratoconus patients. Now they have developed a new treatment that helps strengthen the cornea and stop the damage that keratoconus patients could suffer from this progressive disease.

Corneal Collagen Crosslinking with Riboflavin or (C3-R) is a relatively new treatment. In past decades surgeons would have to perform a corneal transplant to improve the vision of keratoconus patients. Now they have developed a new treatment that helps strengthen the cornea and stop the damage that keratoconus patients could suffer from this progressive disease. The Treatment Application- C3-R is directed under the epithelial cell layer. Located on the surface of the cornea. The surgeon will apply anesthesia drops on the surface of the eye. Then disrupt the epithelial cell layer. So the Riboflavin eye drops will penetrate the stromal portion of the cornea, which is the layer under the epithelium. The Riboflavin drops are then placed on the surface of the cornea. A small UVA light is shone over the eye for about 30 minutes to activate the solution. The procedure is relatively comfortable if the epithelium layer is only disrupted rather than removed. Some surgeons removed the layer, which makes the first week of the procedure uncomfortable. Be sure to check with your doctor to see if they perform the epi-on or epi-off technique. There are several benefits of Corneal Collagen Crosslinking below are a few:

Strengthens the cornea with less evasive procedures- The solution will improve the strength of the cornea over 3-6 months after treatment. It only requires a one time application. And there are less risks associated with C3-R as appose to corneal transplant. Can be combined with INTACS to reverse damage to the cornea- C3-R treatment can be mixed with INTACS reduce the cone shape of the cornea. After the 3 year follow up doctors found that it stopped the increase of cornea curvature values and flattened the mean cone. C3-R Stabilizes Progressive Ectasia- C3-R can give some relief from Progressive Ectasia. It has been proven to stabilize progressive Ectasia. While it is not a complete cure there are high hopes for further treatments of Ectasia. The benefits of C3-R many. Surgeons are further studying and researching C3-R and INTACS. Without question medical sciences are growing rapidly. And each day we are improving the treatments for Keratoconus and other troubling diseases. There is no need to suffer with Keratoconus. Patients now have a wide array of treatments to help them with the progression of this condition.

Article Source: http://www.BestToRead.com/